SERPINA3 and Alzheimer disease: This finding was further validated using a second CSF proteomics dataset, which confirmed significantly higher CSF SERPINA3 levels in 209 AD patients with dementia compared to 187 controls (p=0.005, 20% increase in AD, Figure 2f)15.